JPRN-jRCT2080221461未知2 期
A multiple-center, randomized, double-blind, placebo-controlled, parallel-group comparison study in idiopathic carpal tunnel syndrome
ONO PHARMACEUTICAL CO.,LTD.0 个研究点目标入组 177 人开始时间: 2011年5月18日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 177
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1. 20 years or older of age
- •2. Outpatient
- •3. Idiopathic carpal tunnel syndrome patients
排除标准
- •Patients who needs carpal tunnel syndrome surgery
研究者
相似试验
进行中（未招募）
1 期
clinical trial to assess efficacy and safety of once daily 80 mg propranolol therapy to overall survival for cutaneous melanomamelanomaMedDRA version: 21.1Level: LLTClassification code 10053571Term: MelanomaSystem Organ Class: 100000004864EUCTR2014-003970-18-ITAZIENDA SANITARIA DI FIRENZE23
进行中（未招募）
1 期
Clinical study to assess the effect of QVA149 on cardiac functions in COPD patientschronic obstructive pulmonary disease (COPD)MedDRA version: 19.0Level: LLTClassification code 10010952Term: COPDSystem Organ Class: 100000004855EUCTR2014-004680-21-DEovartis Pharma GmbH62
进行中（未招募）
不适用
A study to evaluate the safety and equivalence of serum phosphate control of a new sevelamer carbonate tablet formulation in comparison with Renvela® in chronic kidney disease patients on hemodialysisEvaluation of the safety and equivalence of serum phosphate control of asevelamer carbonate tablet formulation in comparison withRenvela® in chronic kidney disease patients on hemodialysisMedDRA version: 14.1Level: LLTClassification code 10020712Term: HyperphosphatemiaSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2011-006320-20-BGSynthon BV
招募中
2 期
A multicenter, randomized, double-blind, positive drug parallel controlled clinical trial to evaluate the efficacy and safety of Huolingshengji Keli granules for the treatment of amyotrophic lateral sclerosis (ALS).Amyotrophic lateral sclerosisITMCTR2100004558Peking University Third Hospital
已完成
不适用
A double-blind, parallel, randomized, multicenter study to evaluate the safety and efficacy of NR034 (Ginuril®) versus lactic acid administered as co-adjuvant by vaginal route in women affected by a vaginal yeast infection and who are initiating treatment with clotrimazole vaginal tabletsVaginal infectionUrological and Genital DiseasesISRCTN12908359ovintethical Pharma (Switzerland)42